EOM Pharmaceuticals Holdings, Inc.
IMUC · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $93 | $95 | $28 | $27 |
| - Cash | $1 | $1 | $0 | $1 |
| + Debt | $3 | $3 | $0 | $3 |
| Enterprise Value | $96 | $98 | $28 | $28 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.004 | -0.007 | -0.006 | -0.007 |
| % Growth | 38.8% | -19.6% | 18.8% | – |
| Operating Cash Flow | -$1 | $0 | – | -$0 |
| Capital Expenditures | $0 | $0 | – | $0 |
| Free Cash Flow | -$1 | $0 | – | -$0 |